4.7 Article

The Expanded Role of Chitosan in Localized Antimicrobial Therapy

期刊

MARINE DRUGS
卷 19, 期 12, 页码 -

出版社

MDPI
DOI: 10.3390/md19120697

关键词

chitosan; antimicrobial activity; topical infections; antimicrobial resistance; drug delivery systems; scaffolds; skin infections; vaginal infections

向作者/读者索取更多资源

This review discusses the potential of chitosan in the field of biomedical applications, with a focus on its use in localized antimicrobial therapy to combat increasing antimicrobial resistance. The review categorizes and evaluates chitosan-based delivery systems, addressing challenges related to different administration sites, especially for skin and vaginal infections. It also provides an overview of chitosan's potential in treating ocular, buccal and dental, and nasal infections, as well as remarks on toxicity issues and remaining challenges.
Chitosan is one of the most studied natural origin polymers for biomedical applications. This review focuses on the potential of chitosan in localized antimicrobial therapy to address the challenges of current rising antimicrobial resistance. Due to its mucoadhesiveness, chitosan offers the opportunity to prolong the formulation residence time at mucosal sites; its wound healing properties open possibilities to utilize chitosan as wound dressings with multitargeted activities and more. We provide an unbiased overview of the state-of-the-art chitosan-based delivery systems categorized by the administration site, addressing the site-related challenges and evaluating the representative formulations. Specifically, we offer an in-depth analysis of the current challenges of the chitosan-based novel delivery systems for skin and vaginal infections, including its formulations optimizations and limitations. A brief overview of chitosan's potential in treating ocular, buccal and dental, and nasal infections is included. We close the review with remarks on toxicity issues and remaining challenges and perspectives.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Pharmacology & Pharmacy

Resveratrol-loaded liposomes for topical treatment of the vaginal inflammation and infections

May Wenche Joraholmen, Natasa Skalko-Basnet, Ganesh Acharya, Purusotam Basnet

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2015)

Article Pharmacology & Pharmacy

PEGylated liposomes for topical vaginal therapy improve delivery of interferon alpha

May Wenche Joraholmen, Purusotam Basnet, Ganesh Acharya, Natasa Salko-Basnet

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2017)

Article Pharmacology & Pharmacy

Chitosan-coated liposomes for topical vaginal therapy: Assuring localized drug effect

May Wenche Joraholmen, Zeljka Vanic, Ingunn Tho, Natasa Skalko-Basnet

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2014)

Article Pharmacology & Pharmacy

Localized Therapy of Vaginal Infections and Inflammation: Liposomes-In-Hydrogel Delivery System for Polyphenols

May Wenche Joraholmen, Purusotam Basnet, Mia Jonine Tostrup, Sabrin Moueffaq, Natasa Skalko-Basnet

PHARMACEUTICS (2019)

Article Chemistry, Medicinal

The Antimicrobial Properties of Chitosan Can Be Tailored by Formulation

May Wenche Joraholmen, Abhilasha Bhargava, Kjersti Julin, Mona Johannessen, Natasa Skalko-Basnet

MARINE DRUGS (2020)

Article Pharmacology & Pharmacy

Liposomes-In-Hydrogel Delivery System Enhances the Potential of Resveratrol in Combating Vaginal Chlamydia Infection

May Wenche Joraholmen, Mona Johannessen, Kirsten Gravningen, Mirja Puolakkainen, Ganesh Acharya, Purusotam Basnet, Natasa Skalko-Basnet

PHARMACEUTICS (2020)

Article Chemistry, Medicinal

Chitosomes-In-Chitosan Hydrogel for Acute Skin Injuries: Prevention and Infection Control

Lisa Myrseth Hemmingsen, Kjersti Julin, Luqman Ahsan, Purusotam Basnet, Mona Johannessen, Natasa Skalko-Basnet

Summary: In an era of antimicrobial resistance, novel treatment options are urgently needed to improve the prevention and eradication of infectious skin biofilm-producing pathogens, while enhancing wound healing. Tailoring formulations for acute skin injuries is crucial for proper skin retention and release of antimicrobials.

MARINE DRUGS (2021)

Review Pharmacology & Pharmacy

Nanomedicines for the topical treatment of vulvovaginal infections: Addressing the challenges of antimicrobial resistance

Zeljka Vanic, May Wenche Joraholmen, Natas Skalko-Basnet

Summary: There has been a surprising increase in sexually transmitted infections (STIs) in recent years, coupled with the threat of rising antimicrobial resistance (AMR). The use of nano medicine for treating vaginal infections offers advantages such as localized therapy, reducing systemic drug exposure, and minimizing side effects.

ADVANCED DRUG DELIVERY REVIEWS (2021)

Article Chemistry, Applied

Liposomes-in-chitosan hydrogel boosts potential of chlorhexidine in biofilm eradication in vitro

Lisa Myrseth Hemmingsen, Barbara Giordani, Ann Kristin Pettersen, Beatrice Vitali, Purusotam Basnet, Natasa Skalko-Basnet

Summary: The incorporation of chlorhexidine (CHX) liposomes into chitosan hydrogel significantly enhances its antimicrobial activity, leading to effective eradication of bacteria and biofilms, with potential therapeutic applications for skin infections.

CARBOHYDRATE POLYMERS (2021)

Article Pharmacology & Pharmacy

Toxicity Assessment of Resveratrol Liposomes-in-Hydrogel Delivery System by EpiVaginal™ Tissue Model

May Wenche Joraholmen, Pauliina Damdimopoulou, Ganesh Acharya, Natasa Skalko-Basnet

Summary: A formulation using liposomes loaded with resveratrol (RES) and incorporated into a chitosan hydrogel has been developed for delivering RES to the vaginal site. In vitro experiments showed that this formulation is non-irritant and biocompatible with vaginal tissue at therapeutic concentrations.

PHARMACEUTICS (2022)

Article Microbiology

Chitosan-based delivery system enhances antimicrobial activity of chlorhexidine

Lisa Myrseth Hemmingsen, Pimmat Panchai, Kjersti Julin, Purusotam Basnet, Mona Nystad, Mona Johannessen, Natasa Skalko-Basnet

Summary: Infected chronic skin wounds and other skin infections are becoming a growing concern due to the rise of antimicrobial resistance and biofilm-producing bacteria. In this study, the researchers aimed to investigate the potential of chitosan-containing and chitosan-coated liposomes as a delivery system for the membrane-active antimicrobial chlorhexidine to infected wounds. The results showed that the vesicles comprising chitosan had a slower release rate of chlorhexidine and high cell compatibility. Additionally, the vesicles reduced the inflammatory responses in macrophages and demonstrated strong antibacterial effects against Staphylococcus aureus. These findings suggest that chitosan-containing and chitosan-coated liposomes could serve as excellent platforms for delivering membrane-active antimicrobials to infected wounds.

FRONTIERS IN MICROBIOLOGY (2022)

Article Materials Science, Biomaterials

Tailored anti-biofilm activity-Liposomal delivery for mimic of small antimicrobial peptide

Lisa Myrseth Hemmingsen, Barbara Giordani, Marianne H. Paulsen, Zeljka Vanic, Goril Eide Flaten, Beatrice Vitali, Purusotam Basnet, Annette Bayer, Morten B. Strom, Natasa Skalko-Basnet

Summary: The eradication of bacteria in biofilms is a major challenge in treating chronic wounds. Antimicrobial peptides and their mimics are potential options, but their clinical use is limited. A study explored the use of a synthetic mimic of an antimicrobial peptide incorporated into liposomes to improve its anti-biofilm effect and anti-inflammatory activity. The results showed that the liposomes effectively eradicated biofilms and reduced inflammation, making them a promising therapeutic option for bacteria-infected chronic wounds.

BIOMATERIALS ADVANCES (2023)

暂无数据